Back to search
FDAFDA · Food and drugs·Recall number D-0098-2017

ZENATANE (isotretinoin capsules USP) 20 mg, 30 capsules per prescription pack, Rx Only, Manufactured by: Cipla Limited, Kurkumbh Village Pune 4138012 India, Manufactured for: Dr. Reddy's Laboratories Limited Bachupally 500 090 India, NDC 55111-136-81

Published October 19, 2016 · Recall initiated: August 29, 2016

Summary

FDA records drug Class III recall D-0098-2017, published October 19, 2016 and initiated August 29, 2016. Recalling firm: Dr. Reddy's Laboratories, Inc.; Status: Terminated; Reported quantity: 3,858 prescription packs (115,680 capsules); Lot: Lot # 79KB60205; Exp. 02/18. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications

What to do

Voluntary: Firm initiated · Letter

Get an email if ZENATANE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
ZENATANE
Manufacturer
Dr. Reddy's Laboratories, Inc.
Distributor
nationwide
Lot
Lot # 79KB60205; Exp. 02/18
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was ZENATANE (isotretinoin capsules USP) 20 mg, 30 capsules per prescription pack, Rx Only, Manufactured by: Cipla Limited, Kurkumbh Village Pune 4138012 India, Manufactured for: Dr. Reddy's Laboratories Limited Bachupally 500 090 India, NDC 55111-136-81 recalled?

Yes. FDA published recall D-0098-2017 on October 19, 2016. Reported hazard: Failed Dissolution Specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: ZENATANE.